The survival of patients treated with a new type of ALS therapy has been revealed by Clene Inc. (Nasdaq: ClNN) in the US state of Arizona. The results show significantly improved life for participants in their platform trials.
Source: streetinsider.comPublished on 2023-09-25
Related news
- What does social performance data tell us ? Apparently , not enough
- Turkey New Disinformation Law Affects More Than Meets the Eye - Carnegie Endowment for International Peace
- What New in Civic Tech : FCC May Vote on Broadband Labels
- Recent Developments in the Right to Repair Movement | Butler Snow LLP
- Greece Elevator and Escalator Market Size , Analysis & Growth Forecast Report 2022 - 2028 - Public Private Partnership ( PPP ) Projects to Boost Demand for New Installations - ResearchAndMarkets . com
- Schlumberger launches Enterprise Data Solution
- Reliance JioMart lays off 1 , 000 employees ; govt groups may submit AI rules framework soon
- ICT Agency to speed up digital transformation in Azerbaijan ...
- Payments cards , credit monitoring : What next for installment lenders
- Online Privacy for Nonprofits : A Guide to Better Practices
- CMS Releases 2020 Open Payments Program Data
- Attorney General James Reaches $230 Million Settlement for Treatment and Prevention of Opioid Crisis in New York , Johnson & Johnson Ends Sale of Opioids
- Intelligent Sustainability : The Role of AI in Energy Consumption , Management and New Revenues
- UK tech investment - how it holding up in the Brexit and COVID - 19 world ?
- CorsairM360 Announces Acquisition of Material Intellect